Cortechs.ai

ai develops advanced imaging solutions for medical institutions.ai specializes in advanced AI-powered imaging solutions designed to enhance the diagnosis and monitoring of neurological and oncological diseases. The company offers a suite of products, including NeuroQuant®, which provides precise brain segmentation and volumetric analysis, enabling clinicians to visualize lesions accurately and track volumetric changes over time. Additional offerings include automated software for CT imaging and advanced prostate MRI optimization, aimed at improving diagnostic accuracy and workflow efficiency in medical institutions. These products are utilized by over 1,500 medical institutions across 44 countries, including renowned organizations such as Johns Hopkins Medicine and Cleveland Clinic.ai generates revenue through direct partnerships with healthcare institutions that utilize its advanced imaging solutions. The company operates on a subscription model, providing continuous access to its software tools and regular updates. Revenue streams also include one-time licensing fees for its flagship products, such as NeuroQuant® and NeuroAlign CT, along with support and training services offered to clients. Their strategy includes designing new products aimed at enhancing diagnostic capabilities, and they are targeting expansion into additional global markets to broaden their reach and impact in the medical imaging industry.

1. Series C

   Nov 20, 2024

   Amount

   Undisclosed

   Investors

   Locked